Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jinhai International Group Holdings Limited ( (HK:2225) ) just unveiled an update.
Jinhai Medical Technology Limited announced that all resolutions proposed at its Annual General Meeting (AGM) held on June 25, 2025, were unanimously approved by shareholders. The resolutions included the adoption of financial statements, re-election of directors, authorization of director remuneration, re-appointment of auditors, and granting of mandates for share issuance and repurchase. This unanimous approval reflects strong shareholder confidence in the company’s governance and strategic direction, potentially reinforcing its market position and operational stability.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the development and provision of advanced medical products and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 3,828,804
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$7.19B
For detailed information about 2225 stock, go to TipRanks’ Stock Analysis page.